These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9760950)

  • 21. Brain tumor chemotherapy: translation of laboratory experiments into clinical trials.
    Wilson CB; Wheeler K; Levin VA; Rosenblum M; Barker M
    Trans Am Neurol Assoc; 1976; 101():214-6. PubMed ID: 1028238
    [No Abstract]   [Full Text] [Related]  

  • 22. Modeling mass transfer from carmustine-loaded polymeric implants for malignant gliomas.
    Pereira DY; Yip AT; Lee BS; Kamei DT
    J Lab Autom; 2014 Feb; 19(1):19-34. PubMed ID: 23975389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing new methods for the treatment of malignant brain tumours: local delivery of anti-neoplastic agents using biodegradable polymers.
    Olivi A; DiMeco F; Bohan E; Brem H
    Forum (Genova); 2000; 10(2):152-65. PubMed ID: 10875976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracavitary chemotherapy (Gliadel) and oral low-dose etoposide for recurrent anaplastic ependymoma.
    Sardi I; Sanzo M; Giordano F; Sandri A; Mussa F; Donati PA; Genitori L
    Oncol Rep; 2008 May; 19(5):1219-23. PubMed ID: 18425379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Release of a nitrosourea derivative from refillable silicone rubber implants for the treatment of intraocular malignancies.
    Refojo MF; Liu HS; Leong FL; Sidebottom D
    J Bioeng; 1978; 2(5):437-45. PubMed ID: 744769
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapeutic drug transport to brain tumor.
    Arifin DY; Lee KY; Wang CH
    J Control Release; 2009 Aug; 137(3):203-10. PubMed ID: 19376172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined treatment of glyal and metastatic tumors of the brain].
    Fadeev BP; Zhabina RM
    Vestn Khir Im I I Grek; 2005; 164(1):80-2. PubMed ID: 15957817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of carmustine loaded polyanhydride wafers for treating brain tumors.
    Domb AJ; Israel ZH; Elmalak O; Teomim D; Bentolila A
    Pharm Res; 1999 May; 16(5):762-5. PubMed ID: 10350022
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment for malignant glioma].
    Shibui S
    No To Shinkei; 2005 Dec; 57(12):1027-33. PubMed ID: 16375187
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
    Doolittle ND; Abrey LE; Ferrari N; Hall WA; Laws ER; McLendon RE; Muldoon LL; Peereboom D; Peterson DR; Reynolds CP; Senter P; Neuwelt EA
    Clin Cancer Res; 2002 Jun; 8(6):1702-9. PubMed ID: 12060607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New chemotherapy options for the treatment of malignant gliomas.
    Soffietti R; Rudà R; Trevisan E
    Anticancer Drugs; 2007 Jul; 18(6):621-32. PubMed ID: 17762390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A numerical study of the distribution of chemotherapeutic drug carmustine in brain glioblastoma.
    Chen H; Hu G; Ouyang D
    Drug Deliv Transl Res; 2022 Jul; 12(7):1697-1710. PubMed ID: 34651289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computer simulation of the delivery of etanidazole to brain tumor from PLGA wafers: comparison between linear and double burst release systems.
    Tan WH; Wang F; Lee T; Wang CH
    Biotechnol Bioeng; 2003 May; 82(3):278-88. PubMed ID: 12599254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of factors influencing the response of experimental brain tumors to therapy.
    Wheeler KT
    Cancer Treat Rep; 1981; 65 Suppl 2():75-81. PubMed ID: 7346151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging.
    Chenevert TL; McKeever PE; Ross BD
    Clin Cancer Res; 1997 Sep; 3(9):1457-66. PubMed ID: 9815831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of mustoforan in management of malignant glioma].
    Kobiakov GL
    Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
    [No Abstract]   [Full Text] [Related]  

  • 37. Measurement of sister chromatid exchange induction in intracerebral brain tumors as a method for evaluation of therapeutic drug combinations.
    Bodell WJ
    Anticancer Res; 2000; 20(5A):3099-103. PubMed ID: 11062728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection.
    Hughes MA; Parisi M; Grossman S; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1423-6. PubMed ID: 16029802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for postcraniotomy surgical site infection after 1,3-bis (2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement.
    McGovern PC; Lautenbach E; Brennan PJ; Lustig RA; Fishman NO
    Clin Infect Dis; 2003 Mar; 36(6):759-65. PubMed ID: 12627360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization.
    Elkharraz K; Faisant N; Guse C; Siepmann F; Arica-Yegin B; Oger JM; Gust R; Goepferich A; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):127-36. PubMed ID: 16490330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.